人工智能赋能缺氧缺血性脑病康复的新理念OA

It remains a critical point in clinical research to improve severe adverse neurodevelopmental outcomes caused by hypoxic-ischemic encephalopathy(HIE).Artificial Intelligence(AI)is increasingly demonstrating advantages in neonatal HIE management,including early therapeutic decision-making,prediction of long-term prognosis,development of precision rehabilitation protocol,and the application of telemedicine.AI-powered approaches are expected to redefine traditional diagnostic and therapeutic paradigms and significantly improve adverse neurodevelopmental outcomes of HIE.However,AI-based diagnostic and therapeutic paradigms of HIE will bring benefits to HIE children,but further clinical data is needed in terms of the concomitant safety risks and broad applicability in various situations.